FIS: Goldman Sachs cuts target price to $44 from $52
FIS•Goldman Sachs cut its target price for FIS to $44 from $52.
Related News
Daxor to exhibit Blood Volume Analysis platform at ASN Kidney Week 2026
DXR•
J&J beats earnings estimates, eyes hip-knee unit spinoff by mid-2027
JNJ•
Accelevation enters new $650 million senior secured credit agreement, replaces prior facilities
ACCV•
Tradewinds Universal targets resilient consumer industries to build recurring revenue streams
TRWD•
Agilent Technologies enters definitive agreement to acquire Proscia
A•